SE9801536L - Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning - Google Patents

Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning

Info

Publication number
SE9801536L
SE9801536L SE9801536A SE9801536A SE9801536L SE 9801536 L SE9801536 L SE 9801536L SE 9801536 A SE9801536 A SE 9801536A SE 9801536 A SE9801536 A SE 9801536A SE 9801536 L SE9801536 L SE 9801536L
Authority
SE
Sweden
Prior art keywords
beta
sitostanol
sitosterol
cholesterol
composition containing
Prior art date
Application number
SE9801536A
Other languages
English (en)
Other versions
SE512958C2 (sv
SE9801536D0 (sv
Inventor
Kjell Sjoeberg
Sergej Bolkhovets
Original Assignee
Triple Crown Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20411164&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9801536(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of SE9801536D0 publication Critical patent/SE9801536D0/sv
Priority to SE9801536A priority Critical patent/SE512958C2/sv
Application filed by Triple Crown Ab filed Critical Triple Crown Ab
Priority to DK99948541T priority patent/DK1009385T4/da
Priority to DE69909413T priority patent/DE69909413T3/de
Priority to EP99948541A priority patent/EP1009385B2/en
Priority to AU43035/99A priority patent/AU4303599A/en
Priority to US09/509,281 priority patent/US6491952B1/en
Priority to AT99948541T priority patent/ATE244557T1/de
Priority to PCT/SE1999/000721 priority patent/WO1999056729A1/en
Publication of SE9801536L publication Critical patent/SE9801536L/sv
Publication of SE512958C2 publication Critical patent/SE512958C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0056—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/56—Cocoa products, e.g. chocolate; Substitutes therefor making liquid products, e.g. for making chocolate milk drinks and the products for their preparation, pastes for spreading, milk crumb
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/04—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing vitamins, antibiotics, other medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Confectionery (AREA)
  • Edible Oils And Fats (AREA)
SE9801536A 1998-04-30 1998-04-30 Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning SE512958C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9801536A SE512958C2 (sv) 1998-04-30 1998-04-30 Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
PCT/SE1999/000721 WO1999056729A1 (en) 1998-04-30 1999-04-30 Cholesterol lowering composition
DK99948541T DK1009385T4 (da) 1998-04-30 1999-04-30 Sammensætning til sænkning af kolesterolniveau
AT99948541T ATE244557T1 (de) 1998-04-30 1999-04-30 Zusammensetzung zur senkung des cholesterinspiegels
DE69909413T DE69909413T3 (de) 1998-04-30 1999-04-30 Zusammensetzung zur senkung des cholesterinspiegels
EP99948541A EP1009385B2 (en) 1998-04-30 1999-04-30 Cholesterol level lowering composition
AU43035/99A AU4303599A (en) 1998-04-30 1999-04-30 Cholesterol lowering composition
US09/509,281 US6491952B1 (en) 1998-04-30 1999-04-30 Cholesterol lowering composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801536A SE512958C2 (sv) 1998-04-30 1998-04-30 Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning

Publications (3)

Publication Number Publication Date
SE9801536D0 SE9801536D0 (sv) 1998-04-30
SE9801536L true SE9801536L (sv) 1999-10-31
SE512958C2 SE512958C2 (sv) 2000-06-12

Family

ID=20411164

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801536A SE512958C2 (sv) 1998-04-30 1998-04-30 Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning

Country Status (8)

Country Link
US (1) US6491952B1 (sv)
EP (1) EP1009385B2 (sv)
AT (1) ATE244557T1 (sv)
AU (1) AU4303599A (sv)
DE (1) DE69909413T3 (sv)
DK (1) DK1009385T4 (sv)
SE (1) SE512958C2 (sv)
WO (1) WO1999056729A1 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123978A (en) * 1998-08-31 2000-09-26 Mcneil-Ppc, Inc. Stable salad dressings
US6376481B2 (en) 1998-09-02 2002-04-23 Mcneil-Ppc, Inc. Sterol esters in tableted solid dosage forms
US6242001B1 (en) 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
CN1244281C (zh) * 1999-11-03 2006-03-08 福布斯梅迪泰克公司 包含食用油或脂肪和基本上溶于其中的植物甾醇和/或植物甾烷醇的组合物
US6677327B1 (en) 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions
AU2001253294A1 (en) 2000-04-14 2001-10-30 Mars, Incorporated Compositions and methods for improving vascular health
US7144595B2 (en) * 2001-11-16 2006-12-05 Brandeis University Prepared foods containing triglyceride-recrystallized non-esterified phytosterols
US6623780B1 (en) 2002-03-26 2003-09-23 Cargill, Inc. Aqueous dispersible sterol product
KR101153459B1 (ko) 2002-06-12 2012-06-07 더 코카콜라 컴파니 식물성 스테롤을 함유하는 음료
US7306819B2 (en) 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
AU2003249894B2 (en) * 2002-07-26 2007-05-24 Unilever Plc Phytosterols or phytostanols and their use in food products
US7329429B2 (en) * 2003-09-25 2008-02-12 Chimel Mark J Bars and confectioneries containing cocoa solids having a high cocoa polyphenol content and sterol/stanol esters and processes for their preparation
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
DE602005010972D1 (de) * 2004-01-30 2008-12-24 Unilever Nv Teilchenförmiges produkt, das phytosterole enthält, sowie nahrungsmittelzusammensetzungen, die dieses weissmittel enthalten
US20060035009A1 (en) 2004-08-10 2006-02-16 Kraft Foods Holdings, Inc. Compositions and processes for water-dispersible phytosterols and phytostanols
US20070026126A1 (en) * 2005-08-01 2007-02-01 Bryan Hitchcock Sterol fortified beverages
US7575768B2 (en) * 2005-09-07 2009-08-18 Brandeis University Dietary supplements and prepared foods containing triglyceride-recrystallized non-esterified phytosterols
US7601380B2 (en) * 2005-11-17 2009-10-13 Pepsico, Inc. Beverage clouding system and method
SE532965C2 (sv) * 2008-02-06 2010-05-25 Edio Healthcare Ab Förfarande för framställning av mikropartiklar innehållande växtsterol
US9125425B2 (en) 2010-09-22 2015-09-08 Conopco, Inc. Edible fat continuous spreads
US8039025B1 (en) 2010-10-15 2011-10-18 Life Plus, LLC Methods and dosage forms for the treatment of human cancers
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
FI125947B (sv) 2013-07-05 2016-04-29 Ravintoraisio Oy Serum kolesterolsänkande sammansättning
EP3113629A1 (en) * 2014-03-03 2017-01-11 Raisio Nutrition Ltd Serum cholesterol lowering edible product
US11369895B2 (en) * 2017-01-20 2022-06-28 Nutech Ventures Nanoporous starch aerogels impregnated with phytosterols and methods of preparing the nanoporous starch aerogels

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA72698B (en) 1972-02-03 1973-09-26 Liebenberg R W Method of preparing medicinal compositions
US3881005A (en) 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
US4218334A (en) † 1975-06-06 1980-08-19 Henkel Corporation Phytosterol blends
JPS62126966A (ja) * 1985-11-27 1987-06-09 Nisshin Oil Mills Ltd:The 改良されたインスタントパウダ−組成物
DE3829643A1 (de) 1988-09-01 1990-03-15 Roecar Holdings Nv Phyto- und zoosterole und deren derivate mit verbesserter wasserloeslichkeit
DE4038385C2 (de) 1990-12-01 1998-09-17 Hoyer Gmbh & Co Kg Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
US5244887A (en) 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
CA2091152C (en) † 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
JPH06329588A (ja) † 1993-05-19 1994-11-29 Riken Vitamin Co Ltd 水分散性モノグリセリド
DE69824501T2 (de) † 1997-08-22 2004-11-04 Unilever N.V. Fettenthaltende Nahrungsmittelprodukte mit Sterolen
US6423363B1 (en) † 1997-08-22 2002-07-23 Lipton, Division Of Conopco, Inc. Aqueous dispersion
IN185730B (sv) * 1998-02-19 2001-04-14 Mcneil Ppc Inc
FI109327B (sv) * 1998-02-27 2002-07-15 Spice Sciences Oy Förfarande för framställning av en fettlik blandning av beta-sitosterol som sänker total- och LDL-kolesterolhalten i serum
CN1267030C (zh) * 1998-03-24 2006-08-02 花王株式会社 饮料产品

Also Published As

Publication number Publication date
WO1999056729B1 (en) 1999-12-09
ATE244557T1 (de) 2003-07-15
US6491952B1 (en) 2002-12-10
SE512958C2 (sv) 2000-06-12
DE69909413T3 (de) 2007-08-16
EP1009385B2 (en) 2007-01-03
AU4303599A (en) 1999-11-23
DE69909413T2 (de) 2004-06-09
DK1009385T4 (da) 2007-04-23
EP1009385A2 (en) 2000-06-21
WO1999056729A1 (en) 1999-11-11
SE9801536D0 (sv) 1998-04-30
DE69909413D1 (de) 2003-08-14
DK1009385T3 (da) 2003-11-03
EP1009385B1 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
SE9801536L (sv) Kolesterolsänkande komposition innehållande beta-sitosterol och/eller beta-sitostanol samt förfarande för dess framställning
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
FI101703B1 (sv) Förfarande för framställning av nya 2,6-dialkyl-4-silyl-fenoler användbara som antiaterosklerotiska medel
EP2298301A3 (en) Medicaments for increasing endogenous Erythropoietin (EPO)
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
DE69617088D1 (de) Verfahren zur Herstellung von kristallisiertem Maltit und diesen enthaltenden Kristallinen.
DE3581097D1 (de) Glaskeramisches material, kondensator aus diesem material und verfahren zur herstellung von letzterem.
PL338794A1 (en) Blood plasma for versatile application
AU6881791A (en) Mammalian pancreatic cholesterol esterase
ATE253917T1 (de) Nrihydroxstilbene enthaltende produkte und deren derivate und verfahren zur deren herstellung und ihre verwendung
AU1319895A (en) Cyclodextrin derivatives for solubilising hydrophobic chemical compounds such as drugs, and methods for preparing same
FR2763946B1 (fr) Composes stabilisants et leurs melanges, procede pour les preparer, composition les contenant et procede les utilisant
GB9126725D0 (en) Process
AU2002340670A1 (en) Lipid carrier compositions and methods for improved drug retention
DE59912242D1 (de) Verfahren zur herstellung von (s,s)-benzyl-2,8-diazabicyclo(4.3.0)nonan
HUP0103754A3 (en) Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound
DE69008368T2 (de) Verfahren zur Herstellung von (+)-(2S,3S)-3-hydroxy-2-(4-methoxy-phenyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-on-Derivaten.
ATE152118T1 (de) Kardioaktive 17b-(3-furyl) und 17b-(4- pyridazinyl)-5beta, 14beta-androstan derivate, verfahren zu ihrer herstellung und pharmazeutische präparate davon
DE58900821D1 (de) Verfahren zur herstellung von phosphororganischen derivaten des 2,4-di-t-butylphenols, der 4,4'-dihalogenmagnesium-verbindungen des biphenyls und die verwendung der phosphororganischen derivate zur stabilisierung von kunststoffen, insbesondere in polyolefinformmassen.
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
AU2502899A (en) Method for the elimination of pathogens from solutions containing proteins
AU8245098A (en) Novel triterpene glycoside compound, process for preparation thereof and anti-cancer composition containing the same
AU3941095A (en) The method of production of interior-lining articles from gy psum containing materials. form for production of interior-l ining articles
ATE257476T1 (de) Verfahren zur herstellung von phytosterinen
DE59813058D1 (de) Verfahren zur Herstellung von Enzymen bzw. Enzymkomplexen

Legal Events

Date Code Title Description
NUG Patent has lapsed